Pharmahungary Group as a Hungarian SME is ready to join Horizon Europe grant applications with innovative preclinical and clinical R&D services.
A paradigm change in the preclinical proof-of-concept studies of cardioprotective drugs.
Multi center small and large animal studies for cardiovascular diseases are available at Pharmahungary Group
Pharmahungary Group miRNA therapy – open for lead investors and co-development partners
Founder & CEO one of 7,000 researchers worldwide
Accessibility Tools